As of April 2024 Medifast has a market cap of $0.36 Billion. This makes Medifast the world's 6323th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.36 B | -50.05% |
2023 | $0.73 B | -41.91% |
2022 | $1.26 B | -48.19% |
2021 | $2.43 B | 5.27% |
2020 | $2.31 B | 79.26% |
2019 | $1.28 B | -13.12% |
2018 | $1.48 B | 78.1% |
2017 | $0.83 B | 68.9% |
2016 | $0.49 B | 37.63% |
2015 | $0.35 B | -11.54% |
2014 | $0.40 B | 18.22% |
2013 | $0.34 B | -5.67% |
2012 | $0.36 B | 71.4% |
2011 | $0.21 B | -52.43% |
2010 | $0.44 B | -3.05% |
2009 | $0.45 B | 481% |
2008 | $79.11 M | 18.99% |
2007 | $66.48 M | -60.48% |
2006 | $0.16 B | 155.36% |
2005 | $65.87 M | 70.12% |
2004 | $38.72 M | -73.8% |
2003 | $0.14 B | 285.62% |
2002 | $38.32 M | 2554% |
2001 | $1.44 M |
On Apr 24th, 2024 the market cap of Medifast was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.87 B | 138.20% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $93.28 M | -74.50% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | $0.71 M | -99.80% | ๐บ๐ธ USA |